Zifo Technologies has launched an innovative AI-powered Antibody Engineering app on the Snowflake Marketplace, revolutionizing therapeutic antibody design for biopharma companies and research institutions. This cloud-native GenAI platform, built on the Snowflake Data Cloud, enhances the drug discovery process by enabling faster development and optimization of antibodies while maintaining the security of sensitive data. The app integrates advanced AI models like ProtGPT2, ESM, and RoBERTa into a streamlined workflow, allowing users to fine-tune these models on proprietary datasets for generating novel antibody sequences and predicting their 3D structures.
Chris McClure, Head of Solution Services for Zifo in North America, emphasizes that this app serves as a strategic partner in modern drug discovery. By offering high-performance capabilities for handling large datasets, Zifo’s Antibody Engineering app aims to improve the hit rate for high-affinity therapeutic antibodies, addressing critical challenges in traditional drug development. Discover more at Zifo Technologies.
